It has also been reported that Tim-3+ T cells in head and neck cancer are resistant to PD-1 blockade alone and that there is crosstalk between Tim-3 and PD-1 in CD8 T cells via PI3K/AKT signaling40. Here, HAVCR2 is linked to head and neck cancer.